
Ondansetron (4mg)
Active composition
Ondansetron acts as a selective serotonin 5-HT3 receptor antagonist, inhibiting the action of serotonin in the chemoreceptor trigger zone and preventing nausea and vomiting.
Medical applications
Emigo-MD Tablet contains Ondansetron, a medication used to help prevent nausea and vomiting. It works by blocking serotonin receptors in the brain that are responsible for triggering the vomiting reflex. By preventing the activation of these receptors, the medicine helps control nausea and reduce vomiting episodes. The mouth dissolving tablet formulation allows it to dissolve quickly in the mouth without requiring water, making it convenient to take when nausea occurs. This formulation is especially useful for patients who may find it difficult to swallow conventional tablets. By providing effective symptom control, the medicine helps improve comfort and allows patients to better tolerate medical treatments or certain health conditions. It is generally used according to the advice of a healthcare professional. When taken as directed, Emigo-MD Tablet helps manage nausea and vomiting effectively and supports overall patient comfort.
Carbazole Derivative
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Information regarding the use of Emigo-MD Tablet during pregnancy is not available. Please consult your doctor.
High Risk
Information regarding the use of Emigo-MD Tablet during breastfeeding is not available. Please consult your doctor.
Medical Advice
Emigo-MD Tablet is safe to use in patients with kidney disease. No dose adjustment of Emigo-MD Tablet is recommended. However, inform your doctor if you have an underlying kidney disease. Limited information is available in patients taking this medicine for more than one day.
Exercise Caution
It is not known whether Emigo-MD Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
Emigo-MD Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Emigo-MD Tablet may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Emigo-MD Tablet

Ondansetron (4mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Ondansetron acts as a selective serotonin 5-HT3 receptor antagonist, inhibiting the action of serotonin in the chemoreceptor trigger zone and preventing nausea and vomiting.
Medical applications
Emigo-MD Tablet contains Ondansetron, a medication used to help prevent nausea and vomiting. It works by blocking serotonin receptors in the brain that are responsible for triggering the vomiting reflex. By preventing the activation of these receptors, the medicine helps control nausea and reduce vomiting episodes. The mouth dissolving tablet formulation allows it to dissolve quickly in the mouth without requiring water, making it convenient to take when nausea occurs. This formulation is especially useful for patients who may find it difficult to swallow conventional tablets. By providing effective symptom control, the medicine helps improve comfort and allows patients to better tolerate medical treatments or certain health conditions. It is generally used according to the advice of a healthcare professional. When taken as directed, Emigo-MD Tablet helps manage nausea and vomiting effectively and supports overall patient comfort.
Carbazole Derivative
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Information regarding the use of Emigo-MD Tablet during pregnancy is not available. Please consult your doctor.
High Risk
Information regarding the use of Emigo-MD Tablet during breastfeeding is not available. Please consult your doctor.
Medical Advice
Emigo-MD Tablet is safe to use in patients with kidney disease. No dose adjustment of Emigo-MD Tablet is recommended. However, inform your doctor if you have an underlying kidney disease. Limited information is available in patients taking this medicine for more than one day.
Exercise Caution
It is not known whether Emigo-MD Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
Emigo-MD Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Emigo-MD Tablet may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Emigo-MD Tablet















